ArticleClinical hypertension2026
Association of physical activity with risk of major adverse cardiovascular events and mortality in Korean adults with hypertension.
Article in Clinical hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Whether higher volumes of physical activity (PA) and a greater proportion of vigorous-intensity physical activity (VPA) within total PA volume are associated with lower risks of major adverse cardiovascular events (MACE) and mortality remains unclear. This study aimed to examine the associations of total PA volume and the proportion of VPA within total PA volume with all-cause mortality and MACE among adults with hypertension. Methods: This nationwide cohort study included 124,370 adults with hypertension from the Korean National Health Insurance Service database (2009-2012), with follow-up through 2019. MACE was defined as a composite of cardiovascular disease (CVD) mortality, myocardial infarction (MI), and ischemic stroke. Multivariate Cox proportional hazards models were used to estimate hazard ratios (HRs) for all-cause mortality and MACE. Results: During a median follow-up of 9.1 years, 11,063 deaths occurred. Higher PA volumes were associated with stepwise reductions in all-cause and CVD mortality. In contrast, risk reductions for ischemic stroke plateaued at higher volumes, whereas reductions in MI risk were evident primarily at the highest volumes. Among 91,113 participants who engaged in any PA, a higher proportion of VPA was associated with lower risks of all-cause mortality (HR, 0.92; 95% confidence interval [CI], 0.87-0.98 for < 50% VPA and HR, 0.85; 95% CI, 0.78-0.93 for ≥ 50% VPA), MI (HR, 0.77; 95% CI, 0.67-0.89 and HR, 0.71; 95% CI, 0.58-0.86, respectively), and ischemic stroke (HR, 0.84; 95% CI, 0.76-0.92 for ≥ 50% VPA) after adjusting for total PA volume. No significant associations were observed between the proportion of VPA and CVD mortality. Conclusions: Among adults with hypertension, a higher PA volume was associated with lower risks of all-cause and CVD mortality. Additionally, a greater proportion of VPA, after accounting for total PA volume, was associated with lower risks of MI and ischemic stroke. These findings suggest that both PA volume and intensity composition may be relevant for cardiovascular risk reduction in individuals with hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.